EUVIMEDEUVIMED entdecken
Crossref

Engineered bacterial outer membrane vesicles enhanced tumor immunotherapy through remodeling tumor stroma and targeted delivery of CD73 siRNA

Lili Cheng, Dan Peng, Zhuoyin Liu, Junjie Tang, Peng Zhang, Meiqi Li, Jing Li, Zhicheng Le, Jie Liu

Biomaterials · 2026-04 · 327 · 123725

DOI: 10.1016/j.biomaterials.2025.123725 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials, 2026-04. Verfasst von Lili Cheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, 518107, PR China. Hauptthemen laut MEDLINE: Immunotherapy, RNA, Small Interfering, 5'-Nucleotidase, Bacterial Outer Membrane. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Guangdong Province, Shenzhen Science and Technology Innovation Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The dense, hyaluronic acid (HA)-rich extracellular matrix (ECM) within tumor microenvironment (TME) acts as a physical barrier to therapeutic agents and limits immune cell infiltration. Concurrently, the hypoxic condition of TME activates CD73-adenosine axis, which promotes tumor angiogenesis and metastasis. Here, a potent tumor immunotherapy platform based on genetically and chemically engineered bacterial outer membrane vesicles (OMV) expressing hyaluronidase (HAase) is designed for the targeted delivery of CD73 siRNA (siCD73). This strategy enables initial degradation of HA-rich ECM, thereby enhancing deep tumor penetration and promoting drug retention. Surface modification of OMV with 3-aminophenylboronic acid (PBA) further facilitates sialic acid-mediated tumor targeting and lysosome escape, resulting in a 4.6-fold CD73 inhibition, which suppresses tumor cell and cancer-associated fibroblasts (CAFs) migration, invasion, and adhesion by downregulating epidermal growth factor receptor, matrix metalloproteinase (MMP2/9), and vascular endothelial growth factor (VEGF) secretion. Furthermore, HAase-dependent ECM degradation alleviates deep tumor hypoxia, and inhibits CAFs activation, stromal deposition and angiogenesis by decimating transforming growth factor-β and VEGF secretion, while the intrinsic immunostimulatory properties of OMV leads to more intensive anti-tumor M1 macrophage polarization, dendritic cell maturation, and natural killer cell and cytotoxic T cell infiltration. By comprehensively reprogramming the immunosuppressive TME, the engineered OMV platform demonstrated excellent therapeutic efficacy against primary, recurrent, and metastatic tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyRNA, Small Interfering5'-NucleotidaseBacterial Outer MembraneNeoplasmsAnimalsTumor MicroenvironmentHumansCell Line, TumorMiceExtracellular MatrixHyaluronoglucosaminidaseMice, Inbred BALB CFemale

Stichwörter der Autor:innen

Bacterial outer membrane vesiclesCD73-adenosine axisExtracellular matrixTumor immunotherapysiRNA delivery

Substanzen

RNA, Small Interfering5'-NucleotidaseHyaluronoglucosaminidase

Autor:innen und Institutionen

  • School of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, 518107, PR China.
  • School of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, 518107, PR China. Electronic address: lezhicheng@mail.sysu.edu.cn.
  • School of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, 518107, PR China; Guangdong Provincial Key Laboratory of Sensor Technology and Biomedical Instrument, Sun Yat-sen Univers…

Förderung

  • National Key Research and Development Program of China
  • Natural Science Foundation of Guangdong Province
  • Shenzhen Science and Technology Innovation Program
  • Shenzhen Science and Technology Innovation Committee

Zitieren

APA

Cheng, L., Peng, D., Liu, Z., Tang, J., Zhang, P., Li, M., Li, J., Le, Z., & Liu, J. (2026). Engineered bacterial outer membrane vesicles enhanced tumor immunotherapy through remodeling tumor stroma and targeted delivery of CD73 siRNA. Biomaterials, 327, 123725. https://doi.org/10.1016/j.biomaterials.2025.123725

Vancouver

Cheng L, Peng D, Liu Z, Tang J, Zhang P, Li M, et al. Engineered bacterial outer membrane vesicles enhanced tumor immunotherapy through remodeling tumor stroma and targeted delivery of CD73 siRNA. Biomaterials. 2026;327:123725. doi:10.1016/j.biomaterials.2025.123725

BibTeX
@article{Cheng2026,
  author = {Cheng, Lili and Peng, Dan and Liu, Zhuoyin and Tang, Junjie and Zhang, Peng and Li, Meiqi and Li, Jing and Le, Zhicheng and Liu, Jie},
  title = {Engineered bacterial outer membrane vesicles enhanced tumor immunotherapy through remodeling tumor stroma and targeted delivery of CD73 siRNA},
  journal = {Biomaterials},
  year = {2026},
  volume = {327},
  pages = {123725},
  doi = {10.1016/j.biomaterials.2025.123725}
}
Kostenlos starten →